Zimmer Biomet Holdings (ZBH) Gets a Hold From Wells Fargo
2024's 'Biggest Loses' That Could See Reversal in 2025
Returns Are Gaining Momentum At Zimmer Biomet Holdings (NYSE:ZBH)
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference
RBC Capital Maintains Zimmer Biomet Holdings(ZBH.US) With Buy Rating, Raises Target Price to $130
Zimmer Biomet Holdings To Go Ex-Dividend On December 30th, 2024 With 0.24 USD Dividend Per Share
December 18th (Eastern Time) - $Zimmer Biomet Holdings(ZBH.US)$ is trading ex-dividend on December 30th, 2024.Shareholders of record on December 30th, 2024 will receive 0.24 USD dividend per share
Zimmer Biomet Holdings (NYSE:ZBH) Shareholders Have Endured a 23% Loss From Investing in the Stock Five Years Ago
Truist Financial Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Raises Target Price to $118
Press Release: Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024
Bernstein Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Raises Target Price to $133
This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Zimmer Biomet Holdings: Positioned for Growth With New Product Strategies Despite 2024 Challenges
J.P. Morgan Upgrades Zimmer Biomet Holdings(ZBH.US) to Buy Rating, Raises Target Price to $128
Express News | Zimmer Biomet Holdings Inc : JP Morgan Raises to Overweight From Neutral; Raises Target Price to $128 From $125
ZBH Stock Might Rise Following FDA Nod for OsseoFit
Express News | Zimmer Biomet Holdings Inc - Osseofit Stemless Shoulder Available Commercially in Q1 2025
Express News | Zimmer Biomet Receives FDA Clearance for Osseofit™ Stemless Shoulder System for Total Shoulder Replacement
Zimmer Biomet Receives FDA Clearance for OsseoFit Stemless Shoulder System for Total Shoulder Replacement
Zimmer Biomet Holdings Analyst Ratings
Barclays Cuts Zimmer Biomet Price Target to $118 From $125, Maintains Underweight Rating